PGR: A Protein Involved in Placenta Development and Maintenance

Target Name: PGR

NCBI ID: G5241

Content of Review Report on PGR Target / Biomarker

PGR

PGR: A Protein Involved in Placenta Development and Maintenance

PGR (PRGR-HUMAN) is a protein that is expressed in human placenta, and it is involved in the development and maintenance of the placenta. PGR has been identified as a potential drug target and biomarker for several diseases, including cancer, infertility, and neurological disorders.

The placenta plays a vital role in the development and maintenance of fetal tissue, and it is a source of many important proteins that are required for fetal growth and development. PGR is one of these proteins, and it is expressed in the placenta at high levels during pregnancy.

PGR has been shown to be involved in several important functions in the placenta, including the production of hormones that regulate fetal growth and development, the production of nutrients that support fetal growth, and the regulation of the immune system. PGR has also been shown to be involved in the development and maintenance of the placenta itself, including the formation of blood vessels and the production of cell types that support fetal growth.

As a potential drug target, PGR has been shown to be involved in several diseases, including cancer, infertility, and neurological disorders. PGR has been shown to be involved in the development and progression of cancer, including breast cancer and ovarian cancer. PGR has also been shown to be involved in the development and progression of infertility, including testicular cancer and ovarian hyperstimulation syndrome.

In addition to its involvement in cancer and infertility, PGR has also been shown to be involved in the development and maintenance of neurological disorders. PGR has been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. PGR has also been shown to be involved in the development and progression of epilepsy, and it has been shown to have anti-epileptic properties.

PGR is also a potential biomarker for several diseases, including cancer, infertility, and neurological disorders. PGR has been shown to be a reliable biomarker for the diagnosis of breast cancer, and it has been shown to be associated with the outcomes of patients with breast cancer. PGR has also been shown to be a reliable biomarker for the diagnosis of ovarian cancer, and it has been shown to be associated with the outcomes of patients with ovarian cancer.

In addition to its potential clinical applications, PGR is also a valuable research tool for the study of placenta development and function. PGR has been shown to be involved in several important functions in the placenta, including the production of hormones that regulate fetal growth and development, the production of nutrients that support fetal growth, and the regulation of the immune system. PGR has also been shown to be involved in the development and maintenance of the placenta itself, including the formation of blood vessels and the production of cell types that support fetal growth.

Overall, PGR is a protein that is expressed in the placenta and is involved in the development and maintenance of the placenta. PGR has been shown to be involved in several important functions in the placenta, including the production of hormones that regulate fetal growth and development, the production of nutrients that support fetal growth, and the regulation of the immune system. PGR is a potential drug target and biomarker for several diseases, including cancer, infertility, and neurological disorders, and it is a valuable research tool for the study of placenta development and function.

Protein Name: Progesterone Receptor

Functions: The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Depending on the isoform, progesterone receptor functions as transcriptional activator or repressor

The "PGR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PGR comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets